UBE2F expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.171400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.266600E-01
Normal-vs-Stage2
8.155800E-01
Normal-vs-Stage3
7.875200E-01
Normal-vs-Stage4
7.983800E-01
Stage1-vs-Stage2
3.710000E-01
Stage1-vs-Stage3
9.846800E-01
Stage1-vs-Stage4
3.401000E-01
Stage2-vs-Stage3
4.562600E-01
Stage2-vs-Stage4
9.903400E-01
Stage3-vs-Stage4
6.052000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.820200E-01
Normal-vs-AfricanAmerican
8.509600E-01
Normal-vs-Asian
8.284000E-01
Caucasian-vs-AfricanAmerican
8.994200E-01
Caucasian-vs-Asian
3.260400E-01
AfricanAmerican-vs-Asian
6.097800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.432400E-01
Normal-vs-Female
9.275600E-01
Male-vs-Female
2.566200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.235600E-01
Normal-vs-Age(41-60Yrs)
3.808600E-01
Normal-vs-Age(61-80Yrs)
9.299200E-01
Normal-vs-Age(81-100Yrs)
7.565800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.139600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.609600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.520000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.622400E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.297200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.068600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.525200E-01
Normal-vs-Daily Drinker
7.403800E-01
Normal-vs-Weekly Drinker
8.102200E-01
Normal-vs-Occasional Drinker
5.646200E-01
Normal-vs-Social Drinker
5.251200E-01
Non Drinker-vs-Daily Drinker
9.895400E-01
Non Drinker-vs-Weekly Drinker
2.904200E-01
Non Drinker-vs-Occasional Drinker
5.721800E-02
Non Drinker-vs-Social Drinker
4.868100E-02
Daily Drinker-vs-Weekly Drinker
2.989200E-01
Daily Drinker-vs-Occasional Drinker
7.044500E-02
Daily Drinker-vs-Social Drinker
5.871700E-02
Weekly Drinker-vs-Occasional Drinker
4.938400E-01
Weekly Drinker-vs-Social Drinker
4.290400E-01
Occasional Drinker-vs-Social Drinker
8.917200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.959000E-01
Normal-vs-Grade 2
7.426400E-01
Normal-vs-Grade 3
7.407400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.242200E-01
Grade 1-vs-Grade 3
1.938990E-01
Grade 1-vs-Grade 4
5.959000E-01
Grade 2-vs-Grade 3
9.629800E-01
Grade 2-vs-Grade 4
7.426400E-01
Grade 3-vs-Grade 4
7.407400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.262600E-01
Normal-vs-NonDiabetic
8.581800E-01
Diabetic-vs-NonDiabetic
8.012400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.125400E-01
Normal-vs-NoPancreatitis
8.518000E-01
Pancreatitis-vs-NoPancreatitis
8.444200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.127600E-01
Normal-vs-N1
8.075200E-01
N0-vs-N1
7.680400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.332400E-01
Normal-vs-TP53-NonMutant
5.637400E-01
TP53-Mutant-vs-TP53-NonMutant
7.000100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
